March 22, 2017
Galapagos nets $7.5 million from partner for reaching milestone in a study
Galapagos NV has reached a milestone in a Phase 1 study for cystic fibrosis, it is conducting with its partner AbbVie, …
Pharmaceuticals, Biotechnology and Life Sciences
Tag: GLP3067